Fibroadenoma of the Breast

Definition and Overview

Etiopathogenesis

• Arises from hyperplasia of intralobular stroma and ductal epithelium within a single breast lobule.
• Two-thirds harbor driver mutations in MED12 - a gene encoding a subunit of the mediator complex that regulates RNA polymerase II-dependent transcription. This same mutation is found in uterine leiomyomas (both arising from hormone-responsive stromal cells).
• ~One-third have mutations in RARA (retinoic acid receptor alpha), an estrogen target gene.
• The tumor is hormonally responsive - grows during pregnancy, may regress post-menopause.
• Almost half of females on cyclosporin A after renal transplantation develop multiple bilateral fibroadenomas (likely reactive hyperplasia).
• Robbins Pathologic Basis of Disease, p. 984

Types / Classification

By Histological Pattern

By Size / Special Subtypes

• Simple fibroadenoma - typical, <5 cm, slight increase in cancer RR (1.5-1.7)
• Giant fibroadenoma - >5 cm; descriptive term; excision recommended
• Juvenile fibroadenoma - large, more cellular histologically; occurs in adolescents; excision if >5 cm or persists to adulthood
• Complex fibroadenoma - contains cysts >0.3 cm, sclerosing adenosis, epithelial calcifications, or papillary apocrine change; cancer RR 3.4-3.7; especially high RR (3.0-4.0) with family history of breast cancer
• Myxoid fibroadenoma - sporadic or associated with Carney complex (autosomal dominant; PRKAR1A mutations)
• Bailey and Love's Short Practice of Surgery 28th ed., p. 408; Robbins, p. 984

Morphology / Pathology

Gross

• Well-circumscribed, rubbery, gray-white nodule that bulges above surrounding tissue
• Contains slit-like spaces lined by epithelium
• Usually 2-3 cm; surrounded by a well-defined capsule
• In older females: stroma is densely hyalinized, epithelium is atrophic

Microscopic

• Delicate, often myxoid stroma resembling normal intralobular stroma
• Pericanalicular pattern: stroma surrounds patent round/oval ducts
• Intracanalicular pattern: stroma compresses and distorts ducts into cleft-like spaces (the "interlocking antlers" appearance on H&E)
• Sharply delimited from surrounding tissue

Fig. 23.24 from Robbins: (A) Well-circumscribed mass on radiograph; (B) Rubbery white gross specimen; (C) Intralobular stromal proliferation surrounding and distorting epithelium

• Robbins Pathologic Basis of Disease, p. 984

Clinical Features

• Age: most common in women in their 20s and 30s; pericanalicular type in 15-30 yr, intracanalicular in 35-50 yr
• Presentation: painless, solitary lump (occasionally multiple/bilateral)
• Examination findings:
  • Smooth, firm, well-defined margin
  • Not fixed to skin or deeper structures
  • Highly mobile within breast - classically called "breast mouse" or "floating tumor"
  • No axillary lymphadenopathy
  • No skin changes, no nipple discharge
• Multiple and bilateral fibroadenomas are not uncommon
• Rapid growth during pregnancy (occasionally with infarction) can mimic carcinoma
• Regresses after menopause
• S Das Manual on Clinical Surgery 13th ed., p. 434

Investigations

Triple Assessment (standard approach)

1. Clinical examination - characteristic "breast mouse" mobility
2. Imaging
   • Ultrasonography (preferred in young women <35 yr): well-circumscribed, oval, homogeneous hypoechoic mass with gentle lobulations; posterior acoustic enhancement
   • Mammography: well-circumscribed density; may show "popcorn" calcifications in older/involuting lesions
3. Tissue diagnosis (FNAC / core biopsy)
   • FNAC: shows clusters of benign ductal epithelial cells with background stromal fragments ("antler-horn" stroma)
   • Core biopsy: required if >25 years or atypical features

Differential Diagnosis

Risk of Malignancy

• Bailey and Love 28th ed., p. 414-415; Robbins, p. 984

Management

Conservative (Observation)

• Indicated in women under 25-30 years with typical clinical and US features
• Natural history: regression (~30%), stable, or slow growth
• Regression with tamoxifen or ormeloxifene (anti-oestrogen drugs) has been observed

Indications for Surgical Excision

1. Age >30 years
2. Suspicious features on imaging (e.g., microlobulation)
3. Atypia on histology/cytology
4. Size >5 cm (giant fibroadenoma)
5. Family history of breast cancer
6. Patient preference
7. Excision in elderly should include a rim of normal tissue (to exclude malignancy or phyllodes tumor)

Surgical Technique

• Enucleation through a periareolar or submammary (Gaillard Thomas) incision
• Giant fibroadenomas are often enucleated through a submammary incision

Minimally Invasive Options (emerging)

• Cryoablation - systematic reviews (2025) confirm safety and efficacy for benign fibroadenomas [PMID: 41061430]
• High-Intensity Focused Ultrasound (HIFU) - a 2026 systematic review and meta-analysis showed comparable efficacy and safety to cryoablation [PMID: 42147239]
• Bailey and Love 28th ed.; Sabiston Textbook of Surgery 21st ed.

Fibroadenoma vs. Phyllodes Tumor - Key Comparison

Summary

Fibroadenoma of the Breast

Definition

Etiopathogenesis

• Arises from intralobular stroma of a breast lobule
• 2/3 harbor MED12 mutations (mediator complex subunit regulating RNA Pol II transcription) - same mutation seen in uterine leiomyomas
• ~1/3 have RARA mutations (retinoic acid receptor alpha, an estrogen target gene)
• Tumor is hormonally responsive: grows during pregnancy, regresses post-menopause
• Cyclosporin A after renal transplant can trigger multiple bilateral fibroadenomas

Classification

By Histological Pattern

By Size / Special Subtypes

Pathology / Morphology

Gross

• Well-circumscribed, rubbery, gray-white nodule with a defined capsule
• Bulges above surrounding tissue on cut section
• Contains slit-like spaces lined by epithelium
• In older women: densely hyalinized stroma, atrophic epithelium

Microscopic

• Delicate, myxoid stroma resembling normal intralobular stroma
• Pericanalicular: stroma surrounds patent ducts
• Intracanalicular: stroma distorts ducts into compressed clefts ("antler-horn" pattern)
• Sharp demarcation from surrounding breast tissue

(A) Well-circumscribed mammographic density; (B) Rubbery gray-white gross specimen; (C) H&E showing intralobular stromal proliferation compressing and distorting epithelium - Robbins Pathologic Basis of Disease

Clinical Features

• Most common breast lump in women aged 15-25 years
• Presentation: painless, solitary lump (may be multiple/bilateral)
• Examination:
  • Smooth, firm, well-defined margin
  • Not fixed to skin or deeper structures
  • Highly mobile - classically called "breast mouse" or "floating tumor"
  • No skin tethering, no nipple discharge
  • No axillary lymphadenopathy

Investigations (Triple Assessment)

1. Clinical examination - characteristic mobility
2. Imaging
   • Ultrasonography (preferred <35 yr): oval, well-circumscribed, homogeneous hypoechoic mass; posterior acoustic enhancement
   • Mammography: well-circumscribed density; "popcorn" calcifications in involuting lesions
3. Tissue diagnosis
   • FNAC: clusters of benign ductal epithelial cells + stromal fragments (antler-horn stroma)
   • Core biopsy: if age >25 or atypical features on imaging

A clinically typical fibroadenoma confirmed on ultrasound in a woman under 25 may be observed without biopsy.

Differential Diagnosis

Risk of Malignancy

Management

Conservative (Observation)

• Women <25-30 yr with typical clinical + US features
• Natural history: regression, stability, or slow growth
• Anti-estrogen therapy: tamoxifen or ormeloxifene can induce regression

Indications for Surgical Excision

1. Age >30 years
2. Size >5 cm (giant fibroadenoma)
3. Suspicious / atypical features on imaging
4. Atypia on histology / cytology
5. Family history of breast cancer
6. Rapid growth or change in character
7. Patient's preference
8. In elderly: excise with a rim of normal tissue (to exclude phyllodes or malignancy)

Surgical Technique

• Enucleation through a periareolar or submammary (Gaillard Thomas) incision
• Giant fibroadenomas: submammary incision preferred

Minimally Invasive Ablation (emerging evidence)

• Cryoablation: systematic review (2025, PMID 41061430) confirms safety and efficacy
• HIFU (High-Intensity Focused Ultrasound): 2026 meta-analysis (PMID 42147239) shows comparable outcomes to cryoablation

Fibroadenoma vs. Phyllodes Tumor